← Back to Clinical Trials
Recruiting NCT06084910

NCT06084910 Self-Concept Reinforcement for Early School Readiness

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06084910
Status Recruiting
Phase
Sponsor Children's Hospital Los Angeles
Condition Child Behavior
Study Type INTERVENTIONAL
Enrollment 134 participants
Start Date 2024-07-03
Primary Completion 2028-11-30

Eligibility & Interventions

Sex All sexes
Min Age 2 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Self-Concept Reinforcement for Early School ReadinessReach Out and Read

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 134 participants in total. It began in 2024-07-03 with a primary completion date of 2028-11-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this pilot randomized controlled trial is to evaluate a self-concept intervention (Self-Concept Reinforcement for Early School Readiness (SCR4ESR)) in young African American children using experimental and mixed methods. SCR4ESR provides self-concept themed children's books and advice at health supervision visits of children enrolled at ages 2-4 years. The specific aims of the proposed project are to: 1. assess the feasibility and acceptability of SCR4ESR implementation among parents and providers, 2. evaluate the capacity of SCR4ESR to improve self-concept reinforcement and book-sharing behaviors in parents of young African American children, and 3) evaluate the capacity of SCR4ESR to improve behavioral health and literacy in young African American children. The interviews conducted in Aim 1 will guide refinement of the intervention tested in Aims 2 and 3. The qualitative assessment will be complemented by quantitative trial statistics (e.g., recruitment rate) that inform trial feasibility and acceptability. Finally, the mechanism by which SCR4ESR impacts the primary outcome, behavioral health, and the secondary outcome, literacy, will be evaluated by structural equation modeling. This project will inform the development and implementation of early childhood interventions that improve the health of African Americans.

Eligibility Criteria

Inclusion Criteria: * Parent/Legal guardian must be 18 years old or older * Speak English * Legal guardian of the index 2 to 4-year-old African American child Exclusion Criteria: * Index child has severe cognitive impairment or communication difficulties (i.e., severe intellectual disability or nonverbal) * Plan to move outside of the Children's Hospital Los Angeles (CHLA) service area in the next 15 months * CHLA employee * Participated in Aim 1 interviews

Contact & Investigator

Central Contact

Ashaunta T Anderson, MD, MPH, MSHS

✉ asanderson@chla.usc.edu

📞 (323) 669-2113

Principal Investigator

Ashaunta T Anderson, MD, MPH, MSHS

PRINCIPAL INVESTIGATOR

Children's Hospital Los Angeles

Frequently Asked Questions

Who can join the NCT06084910 clinical trial?

This trial is open to participants of all sexes, aged 2 Years or older, studying Child Behavior. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06084910 currently recruiting?

Yes, NCT06084910 is actively recruiting participants. Contact the research team at asanderson@chla.usc.edu for enrollment information.

Where is the NCT06084910 trial being conducted?

This trial is being conducted at Los Angeles, United States.

Who is sponsoring the NCT06084910 clinical trial?

NCT06084910 is sponsored by Children's Hospital Los Angeles. The principal investigator is Ashaunta T Anderson, MD, MPH, MSHS at Children's Hospital Los Angeles. The trial plans to enroll 134 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology